Form 4 for IVVD Invivyd, Inc.
Accepted 2021-08-12 00:00:00 ET · period of report 2021-08-10 · accession 0001209191-21-051295 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-12 | 2021-08-10 | IVVD | Adimab, LLC | 10% | C - Cnv Deriv | — | +25.86M | 27.85M | +1,303% | — |
| DM | 2021-08-12 | 2021-08-10 | IVVD | Adimab, LLC | 10% | C - Cnv Deriv | $0.00 | -5.17M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-10 | C | A | 25,860,700 | — | 27,845,995 | D | — | — | (F1) Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into Common Stock on a 5:1 basis immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date. |
| 2 | Derivative | Series B Preferred Stock | 2021-08-10 | C | D | 44,076 | $0.00 | 0 | D | — · — to — | 220,380 Common Stock | (F1) Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into Common Stock on a 5:1 basis immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date. |
| 3 | Derivative | Series A Preferred Stock | 2021-08-10 | C | D | 5,000,000 | $0.00 | 0 | D | — · — to — | 25,000,000 Common Stock | (F1) Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into Common Stock on a 5:1 basis immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date. |
| 4 | Derivative | Series C Preferred Stock | 2021-08-10 | C | D | 128,064 | $0.00 | 0 | D | — · — to — | 640,320 Common Stock | (F1) Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into Common Stock on a 5:1 basis immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date. |